Piperacillin-tazobactam
Sponsors
European Organisation for Research and Treatment of Cancer - EORTC, Wyeth is now a wholly owned subsidiary of Pfizer, Phillip Brian Smith, Melinta Therapeutics, Inc., St. Justine's Hospital
Conditions
Acute Kidney InjuryAcute PyelonephritisAmikacinAmoxicillin-clavulanateBone Marrow SuppressionCefazolinCiprofloxacinCommunity-acquired Pneumonia, Influenza, COVID-19
Phase 1
Pharmacokinetics and Safety of Piperacillin-tazobactam in Neonates
CompletedNCT00873327
Start: 2009-10-31End: 2010-07-31Updated: 2018-10-03
Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO)
NCT02466438
Start: 2016-01-31End: 2018-12-31Target: 141Updated: 2018-04-19
Phase 2
Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections
CompletedNCT02753946
Start: 2016-04-30End: 2017-05-30Updated: 2019-03-07
Choosing the Best Antibiotic to Protect Friendly Gut Bacteria During the Course of Stem Cell Transplant
Active, not recruitingNCT03078010
Start: 2017-02-10End: 2027-02-01Updated: 2026-03-04
Comparative Study To Determine The Efficacy, Safety, And Tolerability Of Ceftolozane-Tazobactam
CompletedNCT03485950
Start: 2018-05-16End: 2022-02-16Updated: 2022-03-15
Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics
WithdrawnNCT03862079
Start: 2020-06-01End: 2021-12-31Updated: 2020-03-04
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
CompletedNCT04983901
Start: 2021-09-14End: 2023-10-06Updated: 2024-11-04
Phase 3
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
CompletedNCT00003805
Start: 1997-11-30Updated: 2012-09-24
Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
CompletedNCT02166476
Start: 2014-11-20End: 2016-04-28Updated: 2018-06-11
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
RecruitingNCT02735707
Start: 2016-04-11End: 2028-02-29Target: 20000Updated: 2024-07-12
PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
CompletedNCT02820987
Start: 2016-09-27End: 2018-10-04Updated: 2025-01-16
Does Cefoxitin or Piperacillin-Tazobactam Prevent Postoperative Surgical Site Infections After Pancreatoduodenectomy?
CompletedNCT03269994
Start: 2017-11-21End: 2025-01-28Updated: 2025-10-21
Phase 4
Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock
CompletedNCT02730624
Start: 2014-03-31End: 2017-01-31Updated: 2017-09-20
Aminoglycosides in Early Sepsis
Not yet recruitingNCT06712641
Start: 2026-04-01End: 2033-05-01Target: 1900Updated: 2026-03-16
A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
RecruitingNCT06954129
Start: 2026-01-28End: 2029-07-01Target: 750Updated: 2026-02-13
Unknown Phase
Study Evaluating Piperacillin-Tazobactam on Certain Bacteria in Hematology and Oncology Units
CompletedNCT00167999
Start: 2005-02-28Target: 200Updated: 2007-03-15
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
CompletedNCT00195533
Start: 2001-07-31End: 2005-03-31Updated: 2009-11-16
Pharmacokinetics of Antibiotics During Extracorporeal Membrane Oxygenation (ECMO) Support
TerminatedNCT03922451
Start: 2019-08-27End: 2022-02-28Updated: 2022-03-21
Efficacy of Piperacillin-tazobactam as Empirical Antimicrobial Therapy for VAP Among ESBL-E Carriers.
CompletedNCT04276480
Start: 2022-02-16End: 2024-04-22Updated: 2024-08-28
Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)
RecruitingNCT06426836
Start: 2016-08-19End: 2026-07-01Target: 300Updated: 2026-01-16
Related Papers
14 more papers not shown